Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie von Lilienfeld-Toal

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Acta Haematologica|September 17, 2005
The current status of thalidomide in the management of multiple myelomaAxel Glasmacher, Marie von Lilienfeld-Toal
Oncology Research and Treatment|May 8, 2018
Challenges in Infectious Diseases for HaematologistsMarie von Lilienfeld-Toal, Georg Maschmeyer
Deutsche Medizinische Wochenschrift (1946)|April 24, 2023
[Differences due to socio-economic status, genetic background and sex in cancer and precision medicine - An intersectional approach to close the care gap for marginalized groups]Monika Engelhardt, Annamaria Brioli, Marie von Lilienfeld-Toal
Methods in Molecular Biology (Clifton, N.J.)|December 4, 2019
MAIT Cell Activation by Fungal PathogensSusanne Jahreis, Sarah Boettcher, Marie von Lilienfeld-Toal
Case Reports in Oncology|May 21, 2013
Mixed response to ipilimumab in a melanoma patient with brain metastases: case report and review of the literatureGeorg Feldmann, Peter Brossart, Matthias Zipfel, et al.
Der Onkologe : Organ Der Deutschen Krebsgesellschaft E.V|May 24, 2021
[Vaccination against SARS-CoV-2 in cancer patients]Marie von Lilienfeld-Toal, Christina Rieger, Nicola Giesen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 26, 2007
Zoledronic acid has direct antiproliferative and antimetastatic effect on pancreatic carcinoma cells and acts as an antigen for delta2 gamma/delta T cellsAngela Märten, Marie von Lilienfeld-Toal, Markus W Büchler, et al.
Expert Review of Hematology|January 25, 2017
Safety issues and management of toxicities associated with new treatments for multiple myelomaAnnamaria Brioli, Lars-Olof Mügge, Andreas Hochhaus, et al.
International Journal of Cancer|August 25, 2006
Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing gammadelta T cell cytotoxicityAngela Märten, Marie von Lilienfeld-Toal, Markus W Büchler, et al.
Der Onkologe : Organ Der Deutschen Krebsgesellschaft E.V|March 21, 2022
[Management of infections in patients with cancer]Annika Yanina Classen, Michael Sandherr, Jörg Janne Vehreschild, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Acta Haematologica|September 17, 2005
The current status of thalidomide in the management of multiple myelomaAxel Glasmacher, Marie von Lilienfeld-Toal
Oncology Research and Treatment|May 8, 2018
Challenges in Infectious Diseases for HaematologistsMarie von Lilienfeld-Toal, Georg Maschmeyer
Deutsche Medizinische Wochenschrift (1946)|April 24, 2023
[Differences due to socio-economic status, genetic background and sex in cancer and precision medicine - An intersectional approach to close the care gap for marginalized groups]Monika Engelhardt, Annamaria Brioli, Marie von Lilienfeld-Toal
Methods in Molecular Biology (Clifton, N.J.)|December 4, 2019
MAIT Cell Activation by Fungal PathogensSusanne Jahreis, Sarah Boettcher, Marie von Lilienfeld-Toal
Case Reports in Oncology|May 21, 2013
Mixed response to ipilimumab in a melanoma patient with brain metastases: case report and review of the literatureGeorg Feldmann, Peter Brossart, Matthias Zipfel, et al.
Der Onkologe : Organ Der Deutschen Krebsgesellschaft E.V|May 24, 2021
[Vaccination against SARS-CoV-2 in cancer patients]Marie von Lilienfeld-Toal, Christina Rieger, Nicola Giesen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 26, 2007
Zoledronic acid has direct antiproliferative and antimetastatic effect on pancreatic carcinoma cells and acts as an antigen for delta2 gamma/delta T cellsAngela Märten, Marie von Lilienfeld-Toal, Markus W Büchler, et al.
Expert Review of Hematology|January 25, 2017
Safety issues and management of toxicities associated with new treatments for multiple myelomaAnnamaria Brioli, Lars-Olof Mügge, Andreas Hochhaus, et al.
International Journal of Cancer|August 25, 2006
Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing gammadelta T cell cytotoxicityAngela Märten, Marie von Lilienfeld-Toal, Markus W Büchler, et al.
Der Onkologe : Organ Der Deutschen Krebsgesellschaft E.V|March 21, 2022
[Management of infections in patients with cancer]Annika Yanina Classen, Michael Sandherr, Jörg Janne Vehreschild, et al.
Pageof 10